Covered recipient · General Payments record
MELANIE GRABER
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2023–2024
$681.67
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $528.52 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $223.42 | 16 |
| Amgen Inc. | $104.09 | 4 |
| GlaxoSmithKline, LLC. | $77.04 | 3 |
| Lilly USA, LLC | $76.10 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $26.09 | 1 |
| Janssen Biotech, Inc. | $21.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.68 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103826812 | CMS |
| ABBVIE INC. | $27.41 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103826814 | CMS |
| ABBVIE INC. | $1.73 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103826816 | CMS |
| ABBVIE INC. | $2.74 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103826818 | CMS |
| ABBVIE INC. | $25.93 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103826820 | CMS |
| ABBVIE INC. | $20.56 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103826822 | CMS |
| ABBVIE INC. | $7.35 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103826824 | CMS |
| ABBVIE INC. | $10.75 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103826826 | CMS |
| ABBVIE INC. | $17.29 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103826828 | CMS |
| ABBVIE INC. | $15.73 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103826830 | CMS |
| ABBVIE INC. | $7.51 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103826832 | CMS |
| ABBVIE INC. | $8.60 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103826834 | CMS |
| ABBVIE INC. | $8.11 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103826836 | CMS |
| ABBVIE INC. | $22.71 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103826838 | CMS |
| ABBVIE INC. | $14.70 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103826840 | CMS |
| ABBVIE INC. | $7.62 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103826842 | CMS |
| Amgen Inc. | $23.64 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117264545 | CMS |
| Amgen Inc. | $30.92 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115675272 | CMS |
| Amgen Inc. | $25.20 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115675283 | CMS |
| Amgen Inc. | $24.33 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115675291 | CMS |
| GlaxoSmithKline, LLC. | $31.08 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116307573 | CMS |
| GlaxoSmithKline, LLC. | $29.73 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116482507 | CMS |
| GlaxoSmithKline, LLC. | $16.23 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116411965 | CMS |
| Janssen Biotech, Inc. | $21.78 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078380082 | CMS |
| Lilly USA, LLC | $16.97 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135171268 | CMS |
| Lilly USA, LLC | $17.88 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135188357 | CMS |
| Lilly USA, LLC | $15.01 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135219329 | CMS |
| Lilly USA, LLC | $26.24 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135182308 | CMS |
| Novartis Pharmaceuticals Corporation | $26.09 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086955743 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.